POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | +38.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $21 | -43.2% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $37 | -42.2% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $64 | -99.8% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $42,000 | +35.5% | 12,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $31,000 | -42.6% | 12,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $54,000 | -34.1% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $82,000 | -5.7% | 12,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $87,000 | -27.5% | 12,000 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $120,000 | +4.3% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $115,000 | -12.9% | 12,000 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $132,000 | -17.5% | 12,000 | -33.3% | 0.01% | -23.5% |
| Q3 2020 | $160,000 | – | 18,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 2,945,948 | $5,184,868 | 1.60% |
| Aisling Capital Management LP | 1,043,267 | $1,836,150 | 0.90% |
| Knott David M Jr | 140,921 | $248 | 0.10% |
| XTX Topco Ltd | 233,493 | $410,948 | 0.07% |
| Pentwater Capital Management LP | 5,975,000 | $10,516,000 | 0.07% |
| Atom Investors LP | 49,413 | $86,967 | 0.03% |
| EcoR1 Capital, LLC | 676,296 | $1,190,281 | 0.03% |
| Forefront Analytics, LLC | 26,619 | $46,850 | 0.03% |
| FNY Investment Advisers, LLC | 11,500 | $20 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 80,979 | $142,523 | 0.02% |